|
Instructions for
Authors
ONLINE MANUSCRIPT SUBMISSION: An online
submission and tracking service via internet facilitates a
speedy and cost-effective submission of manuscripts. The full
manuscript should be submitted online via Bentham's
Content Management System (CMS) at http://bsp-cms.eurekaselect.com/index.php/biomeng/
View
Submission Instructions.
Manuscripts must be submitted by one of the
authors of the manuscript, and should not be submitted by
anyone on their behalf. The principal/corresponding author
will be required to submit a Covering Letter along with the
manuscript, on behalf of all the co-authors (if any) to confirm
that the manuscript (or any part of it) has not been published
previously or is not under consideration for publication elsewhere.
Furthermore, any illustration, structure or table that has
been published elsewhere must be reported, and copyright permission
for reproduction must be obtained. The figures from patent
documents are freely available on the databases and may not
require any permission unless stated otherwise.
For all online submissions, please provide soft copies of
all the materials (main text in MS Word or Tex/LaTeX), figures
/ illustrations in TIFF, PDF or JPEG, and chemical structures
drawn in ChemDraw (CDX) / ISISDraw (TGF) as separate files,
while a PDF version of the entire manuscript must also be
included, embedded with all the figures / illustrations /
tables / chemical structures etc. It is advisable that the
document files related to a manuscript submission should always
have the name of the corresponding author as part of the file
name, i.e., Cilli MS text.doc, Cilli MS Figure, 1 etc.
It is imperative that before submission, the author(s)
should carefully proofread the files for special characters,
mathematical symbols, Greek letters, equations, tables, references
and images to ensure that they appear in proper format.
References, figures, tables, chemical structures, etc. should
be referred to in the text at the appropriate places where
they have been first discussed. Figure legends/captions should
also be provided.
A successful electronic submission of the manuscript will
be confirmed by a system-generated email acknowledgement to
the principal/corresponding author immediately. Any queries
therein should be addressed at biomeng@benthamscience.org
or qasit@benthamscience.org
MANUSCRIPTS PUBLISHED: The
journal accepts mini- and full-length review articles and
research articles written in English. Single Topic/Thematic
Issues by invited Guest Editors are also considered for publication.
For the submission of research articles, the author should
have already filed a patent with a leading patent authority
and it is registered and secondly the author has not already
published a research paper on their intellectual property.
Thematic Issues: The Guest Editor (GE) will
invite eminent authors from different countries and different
institutions to contribute articles. As per policy, the contributors
and authors for the thematic issue should not be from the
same institute and with at least half of the contributions
from different countries e.g., USA, UK, France, Canada, Germany,
etc. At the time of submission, the GE will have to provide
a brief description of the proposed topic outlining the aims
& scope of the issue, the list of titles with author names
and affiliations, and keywords on recent patents to be discussed
in the proposed title. The GE and the authors must also provide
specific keywords other than those already in the titles for
the compilation of patent selection.
The thematic issue must need to have about 100-120 printed
pages from contributions by 6 to 8 authors. Alternatively,
a mini-thematic issue can also be considered whereby half
the required number of pages and contributors (i.e. 3 to 4
authors) would be required.
The GE is responsible to review the complete issue and forward
the finalized manuscripts along with an Editorial to the journal's
Editor-in-Chief for approval, within the given time frame.
Proposals may be submitted to
biomeng@benthamscience.org
or qasit@benthamscience.org
Patent Selections: A
separate section of important and recent patents on biomedical
engineering is also included in the journal. The patents annotated
in this section are relevant to the articles published in
this journal issue, categorized by therapeutic areas/targets
and therapeutic agents related to biomedical engineering
MANUSCRIPT LENGTH:
Review Articles: The total number of words
for a published comprehensive review article article is from
8000 to 40000 words, and for mini-review articles from 3000
to 6000 words.
Research Articles: The total number of words
for a published research article is from 4000 to 8000 words.
MANUSCRIPT PREPARATION:
The manuscript should be written in English in a clear, direct
and active style. All pages must be numbered sequentially,
facilitating in the reviewing and editing of the manuscript.
For further convenience, our contracted service provider Eureka
Science can provide assistance to authors for the preparation
of manuscripts.
MANUSCRIPT SECTIONS FOR PAPERS:
Manuscripts may be divided into the following sections:
1. Covering Letter: It is mandatory to submit
a signed covering letter along with the manuscript, by the
author to whom correspondence is to be addressed, delineating
the scope of the submitted article declaring the potential
competing interests, acknowledging contributions from authors
and funding agencies, and certifying that the paper is prepared
according to the 'Instructions for Authors'.
All inconsistencies in the text and in the reference section
and any typographical errors must be carefully checked and
corrected before the submission of the manuscript. The article
should not contain any material or information that may be
unlawful, defamatory, fabricated, plagiarized, or which would,
if published, in any way whatsoever, violate the terms and
conditions as laid down in the copyright agreement. The authors
should acknowledge that the publishers have the legal right
to take appropriate action against the authors for any such
violation of the terms and conditions as laid down in the
copy right agreement.
DOWNLOAD COVERING LETTER.
2. Title: The title of the article should
be precise and brief and must not be more than 120 characters.
Authors should avoid the use of non-standard abbreviations.
The title must be written in title case except for articles,
conjunctions and prepositions.
Title, running title, byline, correspondent footnote and keywords
should be written as presented in original manuscripts.
3. Short Running Title: Authors must provide
a short ‘running title’ of their manuscript.
4. Authors’ Names and Affiliations:
The names of the authors should be provided according to previous
citations or as the authors would want them to be published
along with the institutional affiliations and current address,
telephone, cell & fax numbers and the email address must
be provided, with an asterisk in front of the name of the
principal author. The corresponding author should also be
designated and the full address, telephone, cell & fax
numbers and the email address must be stated to receive correspondence
and galley proofs.
5. Abstract: The abstract summarizing the
essential features of the review or research article should
not exceed 200 words and must include information regarding
patents.
6. Keywords: Authors must provide 6 to 8
keywords in alphabetical order.
7. Text Organization: The main text should
begin on a separate page and should be divided into title
page, abstract and the main text. The text may be subdivided
further according to the areas to be discussed, which should
be followed by the Acknowledgement (if any) and Reference
sections. The Review Article should mention any previous important,
recent and old reviews in the field and contain a comprehensive
discussion starting with the general background of the field.
It should then go on to discuss the salient features of recent
developments along with relevant patents. The authors should
avoid presenting material which has already been published
in a previous review. The authors are advised to present and
discuss their observations in brief. The manuscript style
must be uniform throughout the text and 10pt Times New Roman
fonts should be used. The full term for an abbreviation should
precede its first appearance in the text unless it is a standard
unit of measurement. Italics should be used for Binomial names
of organisms (Genus and Species), for emphasis and for unfamiliar
words or phrases. Non-assimilated words from Latin or other
languages should also be italicized e.g. per se,
et al., in vitro, in vivo, in situ, etc.
For Research Articles, the manuscript should begin with the
title page and abstract followed by the main text, which must
be structured into separate sections as Introduction,
Material and Methods, Results, Discussion, Conclusion,
Current & Future Developments, Conflict of Interest, Acknowledgements
and References. The patent registration number and
patent authority of the author's intellectual property must
be cited in the article.
Protection of Human Subjects and Animals in Research:
When reporting experiments involving human subjects, authors
should indicate whether the procedures followed were in accordance
with the ethical standards of the responsible committee on
human experimentation (institutional and national) and with
the Helsinki Declaration of 1975, as revised in 2000.
For research involving animals, authors should indicate whether
the procedures followed were in accordance with the standards
set forth in the Guide for the Care and Use of Laboratory
Animals(published by the National Academy of Science, National
Academy Press, Washington, D.C.).
Patent Review Coverage: Authors
should review the most recent and important patents based
on the topic covered. Coverage of novel bioactive compounds,
analogs & targets, techniques and drug design in all areas
of biomedical engineering should be emphasized, including
the significance of reported patents.
Current & Future Developments:
The review/research article should conclude with a short section
called “Current & Future Developments”. The
author(s) will give their opinion on the current and future
important developments on the topic discussed in their article.
Symbols and Units: Greek symbols
and special characters often undergo formatting changes and
get corrupted or lost during preparation of a manuscript for
publication. To ensure that all special characters used are
embedded in the text, these special characters should be inserted
as a symbol but should not be a result of any format styling
(Symbol font face) otherwise they will be lost during the
conversion to PDF/XML.
Authors are encouraged to consult reporting guidelines. These
guidelines provide a set of recommendations comprising a list
of items relevant to their specific research design.
Only ISO symbols, written in italic, should be used for the
various parameters. All kinds of measurements should be reported
only in International System of Units (SI). SI units should
always be written in Roman and separated from the numerical
value by a space (whatever the language).
The µ in µg or µm should be in Roman. The
symbol for litre is L and that for minute is min. For temperature,
please use only one of °C, °F or K in the entire manuscript.
As the Angström (1Å = 10-10
m) is not an SI unit, it should be replaced by the nanometre
(1nm = 10-9 m) or by the
picometer (1pm = 10-12 m):
1Å = 0.1nm = 100 pm. Multiple units should be written
with negative superscripts (for example, 25mgµL-1
µs-1). The list of
notations should appear just before the first paragraph of
full text.
A list of symbols and units should be provided if used extensively
throughout the text.
8. List of Abbreviations: If abbreviations
are used in the text either they should be defined in the
text where first used, or a list of abbreviations can be provided.
9. Acknowledgements: Financial contributions
to the work being reported should be clearly acknowledged.
Please acknowledge anyone (individual/company/institution)
who has contributed to the study by making substantial contributions
to conception, design, acquisition of data, or analysis and
interpretation of data, or who was involved in drafting the
manuscript or revising it critically for important intellectual
content. Please list the source(s) of funding for the study,
for each author, and for the manuscript preparation in the
acknowledgement section.
This journal complies with the International Committee of
Medical Journal Editors' Uniform Requirements for Manuscripts
Submitted to Biomedical Journals http://www.icmje.org
and the FDA's Good Reprint Practices for the Distribution
of Medical Journal Articles and Medical or Scientific Reference
Publications on Unapproved New Uses of Approved Drugs and
Approved or Cleared Medical Devices http://www.fda.gov/oc/op/goodreprint.html
.
10. Conflict of Interest: Any potential conflict
of interest should be clearly acknowledged. No patents should
be cited by authors that are in various stages of legal litigation.
11. References: References should be numbered
sequentially [in square brackets] in the text and listed in
the same numerical order in the reference section. All references
must be complete and accurate. Online citations should include
the date of access. Journal titles should conform to the present
Index Medicus abbreviations. It is necessary to list all authors
if the total number of authors is 6 or less, and for more
than 6 authors list the first 6 authors and then use et
al. The reference numbers must be finalized and the bibliography
must be fully formatted before submission.
References should be listed in the following Vancouver Style:
Journal:
[1] Boehm M, Nabel EG. Angiotensin-converting enzyme 2 - A
new cardiac regulator. N Engl J Med 2002; 347: 1795-7.
[2] Moses RG, Luebcke M, Davis WS, et al. Effect of a low-glycemic-index
diet during pregnancy on obstetric outcomes. Am J Clin Nutr
2006; 84: 807-12.
Book:
[2] Crabtree RH. The organometallic chemistry of
the transition metals. 3rd
ed. New York: Wiley & Sons 2001.
Book Chapter:
[3] Yeh DC, Rocco T. In: David EG, Armen HT, Ehrin
JA, April WA, Eds. Integrative cardiovascular pharmacology.
Philadelphia: Lippincott Williams & Wilkins 2005: pp.
375-83.
Conference Proceedings:
[4] Jakeman DL, Withers SGE. Carbohydrate bioengineering:
interdisciplinary approaches. Proceedings of the 4th
Carbohydrate Bioengineering Meeting. Stockholm, Sweden,
June 10-13, 2001.
Meeting Abstract:
[5] Hoffman BJ. Metabolism: amino acid transporters
as targets for therapeutic intervention. American Chemical
Society - 228th National
Meeting. Philadelphia, USA 2004.
Website:
[6] National Library of Medicine. Specialized information
services: Toxicology and environmental health. Available at:
http://sis.nlm.nih.gov/Tox/ToxMain.html (Accessed on: May
23, 2009).
Thesis:
[7] Mackel H. Capturing the spectra of silicon solar
cells. PhD Thesis, The Australian National University, Canberra,
Australia, December 2004.
Patent: As a service, the Publishers can
provide each author a certain number of relevant patents to
assist them in writing their article. All patent application
references will be provided by the author and will be published
as it is.
Patent Reference Style: All inventors’
names of the cited patents must be stated with the title,
publication number and the year of publication e.g. Chesnut
JD, Carrino J, Leong L, Madden K, Gleeson MAG, Fan J, Brasch
MA, Cheo D, Hartley JL, Byrd DRN, Temple GF. Methods and compositions
for synthesis of nucleic acid molecules using multiple recognition
sites. US7198924, 2007.
Citation of the patents will be according to the international
convention as follows:
WO Patents: 1978-2003
[1] Miranda J, Sablotsky S. Solubility parameter
based drug delivery system and method for altering drug saturation
concentration. WO9300058, 1993.
[2] Huang D, Qi DF. Protopanaxadiol and protopanaxatriol
and their use as synergistic anti-cancer agents. WO03024459,
2003.
WO Patents: 2004 onwards
[1] Balzarini J, Liekens S. Anti-cancer combination
therapy. WO2009138507, 2009.
US Patent Applications: 2001 onwards
[1] Strelchenok O. New compounds for the treatment
of cancer. US20010018425, 2001.
[2] Landau BR, Landau S. Treatment of cancer with 2-Deoxygalactose.
US20090163442, 2009.
Issued/Granted US Patents:
[1] Sakamoto I, Takagi K. Anti-cancer device. US4536387,
1985.
[2] Baguley BC, Ching L-M, Philpott M. Cancer treatment by
combination therapy. US7510830, 2009.
EP Patents:
[1] Rimm DL, Wardlaw SC, Levine RA, Fiedler P. Method
for the detection, identification, enumeration and confirmation
of circulating cancer cells and/or hemotologic progenitor
cells in whole blood. EP0919812A2, 1999.
[2] Miller TM, Jamison JM. Non-toxic anti-cancer drug combining
ascorbate, magnesium and a naphthoquinone. EP2034835A2, 2009.
E-citations:
[1] Citations for articles/material published exclusively
online or in open access (free-to-view) , must contain the
exact Web addresses (URLs) at the end of the reference(s),
except those posted on an author’s Web site unless editorially
essential, e.g. ‘Reference: Available from: URL’.
Some important points to remember:
• Superscripts in the in-text citations and reference
section should be avoided.
• Abstracts, unpublished data and personal communications
(which can only be included if prior permission has been obtained)
should not be given in the reference section but they may
be mentioned in the text and details provided as footnotes.
• The authors are encouraged to use a recent version
of EndNote (version 5 and above) or Reference Manager (version
10) when formatting their reference list, as this allows references
to be automatically extracted.
12. Tables (if any):
• Data tables should be submitted in Microsoft Word
table format.
• Each table should include a title/caption being explanatory
in itself with respect to the details discussed in the table.
Detailed legends may then follow.
• Table number in bold font i.e. Table 1, should follow
a title. The title should be in small case with the first
letter in caps. A full stop should be placed at the end of
the title.
• Tables should be embedded in the text exactly according
to their appropriate placement in the submitted manuscript.
• Columns and rows of data should be made visibly distinct
by ensuring that the borders of each cell are displayed as
black lines.
• Tables should be numbered in Arabic numerals sequentially
in order of their citation in the body of the text.
• If a reference is cited in both the table and text,
please insert a lettered footnote in the table to refer to
the numbered reference in the text.
• Tabular data provided as additional files can be submitted
as an Excel spreadsheet.
13. Figures/Illustrations (if any): The quality
of the illustrations printed in the journal largely depends
on the quality of the figures/illustration provided by the
author. The acceptance of a manuscript for publication is
subject to the figures being up to the highest standards in
terms of clarity and resolution. In case, the figures supplied
are not up to the standards required, the authors will be
given the option to either return the manuscripts within one
week with appropriate drawings/figures or they may opt to
have these professionally prepared through the paid professional
service available from Bentham Publishing Services.
The authors should provide the illustrations
as separate files, as well as embedded in the text file, numbered
consecutively in the order of their appearance. Each figure
should include a single illustration. Each figure should be
closely cropped to minimize the amount of white space surrounding
the illustration. If a figure consists of separate parts,
it is important that a single composite illustration file
be submitted, containing all parts of the figure.
Photographs should be provided with a scale
bar if appropriate, as well as high-resolution component files.
Scaling/Resolution
For Line Art image type, which is generally an image based
on lines and text and does not contain tonal or shaded areas,
the preferred file format is TIFF or EPS, with color mode
being Monochrome 1-bit or RGB, in a resolution of 900-1200
dpi.
For Halftone image type, which is generally
a continuous tone photograph and contains no text, the preferred
file format is TIFF, with color mode being or RGB or Grayscale,
in a resolution of 300 dpi.
For Combination image type, which is generally
an image containing halftone in addition to text or line art
elements, the preferred file format is TIFF, with colour mode
being or RGB or Grayscale, in a resolution of 500-900 dpi.
Formats
For illustrations, the following file formats are acceptable:
• Illustrator
• EPS (preferred format for diagrams)
• PDF (also especially suitable for
diagrams)
• PNG (preferred format for photos
or images)
• Microsoft Word (version 5 and above;
figures must be a single page)
• PowerPoint (figures must be a single
page)
• TIFF
• JPEG (conversion should be done using
the original file)
• BMP
• CDX (ChemDraw)
• TGF (ISISDraw)
Bentham Science does not process figures submitted in GIF
format.
If the large size of TIFF or EPS figures acts as an obstacle
to online submission, authors may find that conversion to
JPEG format before submission results in significantly reduced
file size and upload time, while retaining acceptable quality.
JPEG is a 'lossy' format. However, in order to maintain acceptable
image quality, it is recommended that JPEG files are saved
at high or maximum quality.
Files should not be compressed with tools
such as Zipit or Stuffit prior to submission as these tools
will in any case produce negligible file-size savings for
JPEGs and TIFFs, which are already compressed.
Please do not:
1. Supply embedded graphics in your word processor (spreadsheet,
presentation) document;
2. Supply files that are optimized for screen use (like GIF,
BMP, PICT, WPG); the resolution is too low;
3. Supply files that are too low in resolution;
4. Submit graphics that are disproportionately large for the
content.
Image Conversion Tools
There are many software packages, many of them freeware or
shareware, capable of converting to and from different graphics
formats, including PNG.
Good general tools for image conversion include
GraphicConverter on the Macintosh, PaintShop Pro, for Windows,
and ImageMagick, which is available on Macintosh, Windows
and UNIX platforms.
Note that bitmap images (e.g. screenshots)
should not be converted to EPS, since this will result in
a much larger file size than the equivalent JPEG, TIFF, PNG
or BMP, with no increase in quality. EPS should only be used
for images produced by vector-drawing applications such as
Adobe Illustrator or CorelDraw. Most vector-drawing applications
can be saved in, or exported as, EPS format. In case the images
have been originally prepared in an Office application, such
as Word or PowerPoint, then the original Office files should
be directly uploaded to the site, instead of being converted
to JPEG or another format that may be of low quality.
Color Figures/Illustrations
• The cost for the first published page of color figures
is US$ 940; the second additional page will
be for US$ 685 and each subsequent page for
US$ 465.
• Color figures should be supplied in CMYK not RGB colors.
Chemical Structures (if any): Chemical structures
MUST be prepared in ChemDraw (CDX) and provided as separate
file.
Structure Drawing Preferences:
[As according to the ACS style sheet]
Drawing Settings:
Chain angle 120°
Bond spacing 18% of width
Fixed length 14.4 pt (0.500cm, 0.2in)
Bold width 2.0
pt (0.071cm, 0.0278in)
Line width 0.6
pt (0.021cm, 0.0084in)
Margin width 1.6 pt (0.096cm)
Hash spacing 2.5 pt (0.088cm, 0.0347in)
Text settings:
Font Times
New Roman
Size 8
pt
Under the Preference Choose:
Units points
Tolerances 3 pixels
Under Page Setup Use:
Paper US
letter
Scale 100%
14. Supportive/Supplementary Material (if any): We
do encourage to append supportive material, for example a
PowerPoint file containing a talk about the study, a PowerPoint
file containing additional screenshots, a Word, RTF, or PDF
document showing the original instrument(s) used, a video,
or the original data (SAS/SPSS files, Excel files, Access
Db files etc.) provided it is inevitable or endorsed by the
journal's Editor.
Supportive/Supplementary material intended
for publication must be numbered and referred to in the manuscript
but should not be a part of the submitted paper.
In-text citations as well as a section with the heading "Supportive/Supplementary
Material" before the "References" section should
be provided. Here, list all Supportive/Supplementary Material
and include a brief caption line for each file describing
its contents.
Any additional files will be linked into the final published
article in the form supplied by the author, but will not be
displayed within the paper. They will be made available in
exactly the same form as originally provided only
on our website. Please also make sure that each additional
file is a single table, figure or movie (please do not upload
linked worksheets or PDF files larger than one sheet). Supportive/Supplementary
material must be provided in a single zipped file not larger
than 4 MB.
Authors must clearly indicate if these files
are not for publication but meant for the reviewers'/editors'
perusal only.
PERMISSION FOR REPRODUCTION: Published/reproduced
material should not be included unless you have obtained written
permission from the copyright holder, which should be forwarded
to the Editorial Office in case of acceptance of your article
for publication.
For obtaining permission of reproducing any material published
in an article by Bentham Science Publishers, please fill in
the FORM
downloadable from the journal’s Web site and send to
biomeng@benthamscience.org
or qasit@benthamscience.org
for consideration.
REVIEWING AND PROMPTNESS OF PUBLICATION:
All papers submitted for publication are immediately subjected
to editorial scrutiny, usually in consultation with members
of the journal Editorial Advisory Board and outside independent
reviewers. Every effort will be made to peer review submitted
papers quickly. Papers which are delayed by authors in revision
for more than 30 days will have to be re-submitted as a new
submission. Papers accepted for publication are typeset and
proofs are dispatched to authors for any corrections prior
to final publication.
LANGUAGE AND EDITING: Manuscripts submitted
containing many English typographical errors will not be published.
Manuscripts which are accepted for publication on condition
that the written English submitted is corrected, will be sent
a quote by Eureka
Science, a professional language editing company. Authors
from non-English language countries who have poor English
language written skills, are advised to contact the language
editing company prior to submitting their manuscript to the
journal. Please contact Eureka
Science for a language editing quote at e-mail: info@eureka-science.com
stating the total number of words of the article to be edited.
PROOFS: Authors will receive
page proofs of their accepted paper before publications. To
avoid delays in publication, proofs should be checked immediately
for typographical errors and returned within 48 hours. Major
changes are not acceptable at the proof stage. If unable to
send corrections within 48 hours due to some reason, the author(s)
must at least send an acknowledgement on receiving the galley
proofs or the article will be published exactly as received
and the publishers will not be responsible for any error occurring
in the published manuscript in this regard.
The corresponding author will be solely responsible
for ensuring that the revised version of the manuscript incorporating
all the submitted corrections receives the approval of all
the co-authors of the manuscript.
REPRINTS: Each first-named (corresponding)
author will receive electronically five free e-reprints. Reprints
may be ordered from the Publisher prior to publication of
the article. First named authors may also order a personal
print and online subscription of the journal at 50% off the
normal subscription rate by contacting the subscription department
at e-mail: subscriptions@benthamscience.org.
OPEN ACCESS PLUS: Accepted articles can be published online for free open access for all to view. Open access publishing provides the maximum dissemination of the article to the largest audience. Authors must pay for this service. All corresponding authors will be asked to indicate whether or not they wish to pay to have their paper made freely available on publication. If authors do not select the Open Access option, then their article will be published with standard subscription-based access at no charge.
Bentham Science offers authors the choice of open access publication of their articles at a fee of US$ 2,200 per published article which allows indefinite free-to-view online publication with Bentham Science.
For more information please contact us at e-mail: openaccess@benthamscience.org.
COPYRIGHT: Authors who publish
in Bentham Science Journals will transfer copyright to their
work to Bentham Science Publishers. Submission of a manuscript
to the respective journals implies that all authors have read
and agreed to the content of the Covering Letter or the Terms
and Conditions. It is a condition of publication that manuscripts
submitted to this journal have not been published and will
not be simultaneously submitted or published elsewhere. Plagiarism
is strictly forbidden, and by submitting the article for publication
the authors agree that the publishers have the legal right
to take appropriate action against the authors, if plagiarism
or fabricated information is discovered. By submitting a manuscript
the authors agree that the copyright of their article is transferred
to the publishers if and when the article is accepted for
publication. Once submitted to the journal, the author will
not withdraw their manuscript at any stage prior to publication.
PLAGIARISM PREVENTION: Bentham Science Publisher uses the iThenticate software to detect instances of overlapping and similar text in submitted manuscripts. iThenticate software checks content uploaded by a journal editorial office against a database of periodicals, the Internet, and a comprehensive article database. It generates a similarity report, including the percentage overlap between the uploaded article and published material. Any instances of content overlap are treated according to a journal's peer review integrity statement and the policies recommended by the editorial Committee. You are assured that the publisher, where you are submitting your manuscript, is committed to actively combating plagiarism and publishing original research.
E-PUB AHEAD-OF-SCHEDULE:
Bentham Science Publishers are pleased to offer electronic
publication of accepted papers prior to scheduled publication.
These peer-reviewed papers can be cited using the date of
access and the unique DOI number. Any final changes in manuscripts
will be made at the time of print publication and will be
reflected in the final electronic version of the issue. Articles
ahead of schedule may be ordered by pay-per-view at the relevant
links by each article stated via the E-Pub
Ahead of Schedule (http://www.benthamscience.com/biomeng/E-Pub-Ahead-of-Schedule.htm).
DISCLAIMER: Articles appearing in E-Pub Ahead-of-Schedule
sections have been peer-reviewed and accepted for publication
in this journal and posted online before scheduled publication.
Articles appearing here may contain statements, opinions,
and information that have errors in facts, figures, or interpretation.
Accordingly, Bentham Science Publishers, the editors
and authors and their respective employees are not responsible
or liable for the use of any such inaccurate or misleading
data, opinion or information contained of articles in the
E-Pub Ahead-of-Schedule.
|
